Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Echinococcus multilocularis | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0051 | 0.0739 | 0.0739 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0051 | 0.0739 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0069 | 0.1465 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.2728 | 0.2728 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0237 | 0.8066 | 0.8066 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1035 | 0.7062 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0051 | 0.0739 | 0.5 |
Onchocerca volvulus | 0.0153 | 0.4783 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 0.4783 | 0.4783 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0101 | 0.2728 | 0.2728 |
Brugia malayi | Isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0101 | 0.2728 | 0.2728 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1035 | 0.7062 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0051 | 0.0739 | 0.5 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.504 |
Brugia malayi | isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.1465 | 0.1465 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0051 | 0.0739 | 0.5 |
Brugia malayi | hypothetical protein | 0.0153 | 0.4783 | 0.4783 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0051 | 0.0739 | 0.5 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0051 | 0.0739 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0051 | 0.0739 | 0.0739 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0051 | 0.0739 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1035 | 0.1035 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0069 | 0.1465 | 0.1465 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0237 | 0.8066 | 0.8066 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0237 | 0.8066 | 0.8066 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0101 | 0.2728 | 0.2728 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0051 | 0.0739 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1122 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (binding) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.